Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adolescent maturation and injury risk in an elite ballet school: a 7-year cohort study of 506 students.

British journal of sports medicine·2026
Same author

Post-tuberculosis lung disease.

Breathe (Sheffield, England)·2026
Same author

Integrating chest radiography-based TB screening and preventive treatment for household contacts in Pakistan: a pilot study.

BMC infectious diseases·2025
Same author

Programmatic approaches to screening for tuberculosis disease: a situational analysis of seven countries in the Western Pacific Region.

Tropical medicine and health·2025
Same author

Stress-Induced Antibody Aggregates: Insights from Native SEC-MS with Postcolumn Denaturation.

Journal of the American Society for Mass Spectrometry·2025
Same author

Drug-resistant tuberculosis: a priority pathogen for enhanced public health research and practice.

Clinical microbiology reviews·2025

Related Experiment Video

Updated: May 11, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Multidrug-resistant tuberculosis, Somalia, 2010-2011.

Ireneaus Sindani1, Christopher Fitzpatrick, Dennis Falzon

  • 1World Health Organization, Nairobi, Kenya.

Emerging Infectious Diseases
|April 30, 2013
PubMed
Summary

Multidrug-resistant tuberculosis (MDR TB) is a significant public health threat in Somalia. High MDR TB rates in new and previously treated patients challenge effective tuberculosis control efforts.

Keywords:
Mycobacterium tuberculosis and other mycobacteriaSomaliadrug resistancesurveillance

More Related Videos

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Related Experiment Videos

Last Updated: May 11, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Tuberculosis (TB) remains a major global health concern.
  • Drug-resistant TB poses a significant challenge to effective treatment and control.
  • Limited data exists on the prevalence of drug-resistant TB in Somalia.

Purpose of the Study:

  • To determine the prevalence of multidrug-resistant tuberculosis (MDR TB) in Somalia.
  • To assess the burden of drug resistance in new and previously treated TB patients.

Main Methods:

  • A nationwide survey was conducted in 2011.
  • Data was collected from patients diagnosed with TB.

Main Results:

  • Multidrug-resistant tuberculosis (MDR TB) was identified in 5.2% of new TB cases.
  • A high prevalence of 40.8% for MDR TB was observed in previously treated TB patients.
  • These resistance levels are among the highest reported in Africa and the Middle East.

Conclusions:

  • The findings indicate a serious challenge for TB control programs in Somalia.
  • Urgent interventions are needed to address the high burden of MDR TB.
  • Enhanced surveillance and treatment strategies are crucial for effective TB management.